Cargando…

Towards the global equilibrium of COVID‐19: Statistical analysis of country‐level data

In our study, we explore the COVID‐19 dynamics to test whether the virus has reached its equilibrium point and to identify the main factors explaining the current R and case fatality rate (CFR) variability across countries. We present a retrospective study of publicly available country‐level data fr...

Descripción completa

Detalles Bibliográficos
Autor principal: Last, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059201/
https://www.ncbi.nlm.nih.gov/pubmed/35509402
http://dx.doi.org/10.1002/hsr2.592
_version_ 1784698263424729088
author Last, Mark
author_facet Last, Mark
author_sort Last, Mark
collection PubMed
description In our study, we explore the COVID‐19 dynamics to test whether the virus has reached its equilibrium point and to identify the main factors explaining the current R and case fatality rate (CFR) variability across countries. We present a retrospective study of publicly available country‐level data from 50 countries having the highest number of confirmed COVID–19 cases at the end of September 2021. The mean values of country‐level moving averages of R and CFR went down respectively from 1.118 and 6.3% on June 30, 2020 to 1.083 and 3.6% on September 30, 2020 and to 1.015 and 1.8% by September 30, 2021. In parallel, the 10%–90% inter‐percentile range of R and CFR moving averages decreased, respectively, from 0.288 and 13.3% on June 30, 2020, to 0.151 and 7.7% on September 30, 2020, and to 0.107 and 3.3% by September 30, 2021. The slow decrease in the country‐level moving averages of R, approaching the level of 1.0 and accompanied by repeated outbreaks (“waves”) in various countries, may indicate that COVID‐19 has reached its point of stable endemic equilibrium. A regression analysis implies that only a prohibitively high level of herd immunity (about 63%) may stop the endemic by reaching a stable disease‐free equilibrium. It also appears that fully vaccinating about 70% of a country's population should be sufficient for bringing the CFR close to the level of the seasonal flu (about 0.1%). Thus, while the currently available vaccines prove to be effective in reducing the mortality from the existing COVID‐19 variants, they are unlikely to stop the spread of the virus in the foreseeable future. It is noteworthy that government measures restricting people's behavior (such as lockdowns) were not found to have statistically significant effects in the analyzed data.
format Online
Article
Text
id pubmed-9059201
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90592012022-05-03 Towards the global equilibrium of COVID‐19: Statistical analysis of country‐level data Last, Mark Health Sci Rep Original Research In our study, we explore the COVID‐19 dynamics to test whether the virus has reached its equilibrium point and to identify the main factors explaining the current R and case fatality rate (CFR) variability across countries. We present a retrospective study of publicly available country‐level data from 50 countries having the highest number of confirmed COVID–19 cases at the end of September 2021. The mean values of country‐level moving averages of R and CFR went down respectively from 1.118 and 6.3% on June 30, 2020 to 1.083 and 3.6% on September 30, 2020 and to 1.015 and 1.8% by September 30, 2021. In parallel, the 10%–90% inter‐percentile range of R and CFR moving averages decreased, respectively, from 0.288 and 13.3% on June 30, 2020, to 0.151 and 7.7% on September 30, 2020, and to 0.107 and 3.3% by September 30, 2021. The slow decrease in the country‐level moving averages of R, approaching the level of 1.0 and accompanied by repeated outbreaks (“waves”) in various countries, may indicate that COVID‐19 has reached its point of stable endemic equilibrium. A regression analysis implies that only a prohibitively high level of herd immunity (about 63%) may stop the endemic by reaching a stable disease‐free equilibrium. It also appears that fully vaccinating about 70% of a country's population should be sufficient for bringing the CFR close to the level of the seasonal flu (about 0.1%). Thus, while the currently available vaccines prove to be effective in reducing the mortality from the existing COVID‐19 variants, they are unlikely to stop the spread of the virus in the foreseeable future. It is noteworthy that government measures restricting people's behavior (such as lockdowns) were not found to have statistically significant effects in the analyzed data. John Wiley and Sons Inc. 2022-04-22 /pmc/articles/PMC9059201/ /pubmed/35509402 http://dx.doi.org/10.1002/hsr2.592 Text en © 2022 The Authors. Health Science Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Last, Mark
Towards the global equilibrium of COVID‐19: Statistical analysis of country‐level data
title Towards the global equilibrium of COVID‐19: Statistical analysis of country‐level data
title_full Towards the global equilibrium of COVID‐19: Statistical analysis of country‐level data
title_fullStr Towards the global equilibrium of COVID‐19: Statistical analysis of country‐level data
title_full_unstemmed Towards the global equilibrium of COVID‐19: Statistical analysis of country‐level data
title_short Towards the global equilibrium of COVID‐19: Statistical analysis of country‐level data
title_sort towards the global equilibrium of covid‐19: statistical analysis of country‐level data
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059201/
https://www.ncbi.nlm.nih.gov/pubmed/35509402
http://dx.doi.org/10.1002/hsr2.592
work_keys_str_mv AT lastmark towardstheglobalequilibriumofcovid19statisticalanalysisofcountryleveldata